25 XP   0   0   10

Synaptogenix Inc
Buy, Hold or Sell?

Let's analyze Synaptogen together

I guess you are interested in Synaptogenix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Synaptogenix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Synaptogenix Inc

I send you an email if I find something interesting about Synaptogenix Inc.

Quick analysis of Synaptogen (30 sec.)










What can you expect buying and holding a share of Synaptogen? (30 sec.)

How much money do you get?

How much money do you get?
$0.09
When do you have the money?
1 year
How often do you get paid?
33.3%

What is your share worth?

Current worth
$20.75
Expected worth in 1 year
$36.93
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
$16.28
Return On Investment
400.9%

For what price can you sell your share?

Current Price per Share
$4.06
Expected price per share
$3.525 - $4.65
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Synaptogen (5 min.)




Live pricePrice per Share (EOD)

$4.06

Intrinsic Value Per Share

$3.83 - $5.33

Total Value Per Share

$24.58 - $26.07

2. Growth of Synaptogen (5 min.)




Is Synaptogen growing?

Current yearPrevious yearGrowGrow %
How rich?$25.5m$31.3m-$4.6m-17.6%

How much money is Synaptogen making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$981.7k-$348.9k-26.2%
Net Profit Margin-2,423.5%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Synaptogen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#522 / 966

Most Revenue
#768 / 966

Most Profit
#250 / 966

Most Efficient
#804 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Synaptogen? (5 min.)

Welcome investor! Synaptogen's management wants to use your money to grow the business. In return you get a share of Synaptogen.

What can you expect buying and holding a share of Synaptogen?

First you should know what it really means to hold a share of Synaptogen. And how you can make/lose money.

Speculation

The Price per Share of Synaptogen is $4.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Synaptogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Synaptogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $20.75. Based on the TTM, the Book Value Change Per Share is $4.05 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Synaptogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.81-19.9%-0.53-12.9%-0.13-3.3%-0.95-23.4%-0.95-23.4%
Usd Book Value Change Per Share0.000.0%4.0599.7%0.00-0.1%1.1528.4%1.1528.4%
Usd Dividend Per Share0.000.0%0.020.5%0.010.3%0.010.2%0.010.2%
Usd Total Gains Per Share0.000.0%4.07100.2%0.010.3%1.1628.6%1.1628.6%
Usd Price Per Share0.19-0.46-3.46-3.08-3.08-
Price to Earnings Ratio-0.06-0.25--1.71--1.30--1.30-
Price-to-Total Gains Ratio4,546.02-1,136.12--8.23-323.37-323.37-
Price to Book Ratio0.01-0.11-0.85-0.66-0.66-
Price-to-Total Gains Ratio4,546.02-1,136.12--8.23-323.37-323.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.06
Number of shares246
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share4.051.15
Usd Total Gains Per Share4.071.16
Gains per Quarter (246 shares)1,000.95285.43
Gains per Year (246 shares)4,003.791,141.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12139823994811341132
243796579981522682274
36411947120022334023416
48615929160063045364558
510719912200103856705700
612923894240144668056842
715027876280185379397984
817231859320226190739126
91933584136026691020710268
102143982340030761134111410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.016.00.011.1%2.016.00.011.1%2.016.00.011.1%
Book Value Change Per Share1.02.01.025.0%4.07.01.033.3%7.08.03.038.9%7.08.03.038.9%7.08.03.038.9%
Dividend per Share4.00.00.0100.0%6.00.06.050.0%6.00.012.033.3%6.00.012.033.3%6.00.012.033.3%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%8.08.02.044.4%8.08.02.044.4%8.08.02.044.4%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Synaptogen

About Synaptogenix Inc

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development stage. The company focuses on developing Bryostatin-1, a product platform for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-06-19 07:32:09.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Synaptogenix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Synaptogen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Synaptogen to the Biotechnology industry mean.
  • A Net Profit Margin of -9,694.1% means that $-96.94 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Synaptogenix Inc:

  • The MRQ is -9,694.1%. The company is making a huge loss. -2
  • The TTM is -2,423.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9,694.1%TTM-2,423.5%-7,270.6%
TTM-2,423.5%YOY--2,423.5%
TTM-2,423.5%5Y-538.6%-1,885.0%
5Y-538.6%10Y-538.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9,694.1%-168.0%-9,526.1%
TTM-2,423.5%-209.9%-2,213.6%
YOY--242.3%+242.3%
5Y-538.6%-401.7%-136.9%
10Y-538.6%-532.2%-6.4%
1.1.2. Return on Assets

Shows how efficient Synaptogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Synaptogen to the Biotechnology industry mean.
  • -3.2% Return on Assets means that Synaptogen generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Synaptogenix Inc:

  • The MRQ is -3.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.2%TTM-4.1%+0.9%
TTM-4.1%YOY-4.2%+0.1%
TTM-4.1%5Y-10.8%+6.7%
5Y-10.8%10Y-10.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.2%-11.9%+8.7%
TTM-4.1%-11.9%+7.8%
YOY-4.2%-11.3%+7.1%
5Y-10.8%-13.5%+2.7%
10Y-10.8%-14.9%+4.1%
1.1.3. Return on Equity

Shows how efficient Synaptogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Synaptogen to the Biotechnology industry mean.
  • -4.1% Return on Equity means Synaptogen generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Synaptogenix Inc:

  • The MRQ is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-5.1%+1.0%
TTM-5.1%YOY-4.1%-1.0%
TTM-5.1%5Y-12.0%+6.9%
5Y-12.0%10Y-12.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%-14.2%+10.1%
TTM-5.1%-15.7%+10.6%
YOY-4.1%-14.3%+10.2%
5Y-12.0%-19.2%+7.2%
10Y-12.0%-19.7%+7.7%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Synaptogenix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Synaptogen is operating .

  • Measures how much profit Synaptogen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Synaptogen to the Biotechnology industry mean.
  • An Operating Margin of -20,755.4% means the company generated $-207.55  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Synaptogenix Inc:

  • The MRQ is -20,755.4%. The company is operating very inefficient. -2
  • The TTM is -5,188.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-20,755.4%TTM-5,188.9%-15,566.6%
TTM-5,188.9%YOY--5,188.9%
TTM-5,188.9%5Y-1,153.1%-4,035.8%
5Y-1,153.1%10Y-1,153.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20,755.4%-354.6%-20,400.8%
TTM-5,188.9%-225.9%-4,963.0%
YOY--252.2%+252.2%
5Y-1,153.1%-428.3%-724.8%
10Y-1,153.1%-531.1%-622.0%
1.2.2. Operating Ratio

Measures how efficient Synaptogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 207.55 means that the operating costs are $207.55 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Synaptogenix Inc:

  • The MRQ is 207.554. The company is inefficient in keeping operating costs low. -1
  • The TTM is 51.888. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ207.554TTM51.888+155.665
TTM51.888YOY-+51.888
TTM51.8885Y11.531+40.358
5Y11.53110Y11.5310.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ207.5543.004+204.550
TTM51.8883.332+48.556
YOY-3.502-3.502
5Y11.5315.271+6.260
10Y11.5316.915+4.616
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Synaptogenix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Synaptogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.14 means the company has $7.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Synaptogenix Inc:

  • The MRQ is 7.140. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.031. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.140TTM11.031-3.891
TTM11.031YOY36.296-25.265
TTM11.0315Y22.866-11.836
5Y22.86610Y22.8660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1403.767+3.373
TTM11.0314.000+7.031
YOY36.2964.905+31.391
5Y22.8665.883+16.983
10Y22.8666.286+16.580
1.3.2. Quick Ratio

Measures if Synaptogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Synaptogen to the Biotechnology industry mean.
  • A Quick Ratio of 7.37 means the company can pay off $7.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Synaptogenix Inc:

  • The MRQ is 7.375. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.258. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.375TTM9.258-1.883
TTM9.258YOY35.258-26.000
TTM9.2585Y21.745-12.487
5Y21.74510Y21.7450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3753.054+4.321
TTM9.2583.506+5.752
YOY35.2584.756+30.502
5Y21.7455.757+15.988
10Y21.7456.338+15.407
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Synaptogenix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Synaptogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Synaptogen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.18 means that Synaptogen assets are financed with 17.8% credit (debt) and the remaining percentage (100% - 17.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Synaptogenix Inc:

  • The MRQ is 0.178. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.168. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.178TTM0.168+0.010
TTM0.168YOY0.048+0.120
TTM0.1685Y0.079+0.089
5Y0.07910Y0.0790.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1780.330-0.152
TTM0.1680.342-0.174
YOY0.0480.287-0.239
5Y0.0790.368-0.289
10Y0.0790.382-0.303
1.4.2. Debt to Equity Ratio

Measures if Synaptogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Synaptogen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 22.7% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Synaptogenix Inc:

  • The MRQ is 0.227. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.206. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.227TTM0.206+0.021
TTM0.206YOY0.051+0.155
TTM0.2065Y0.093+0.113
5Y0.09310Y0.0930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2270.365-0.138
TTM0.2060.415-0.209
YOY0.0510.370-0.319
5Y0.0930.443-0.350
10Y0.0930.476-0.383
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Synaptogenix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Synaptogen generates.

  • Above 15 is considered overpriced but always compare Synaptogen to the Biotechnology industry mean.
  • A PE ratio of -0.06 means the investor is paying $-0.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Synaptogenix Inc:

  • The EOD is -1.257. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.058. Based on the earnings, the company is expensive. -2
  • The TTM is 0.246. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.257MRQ-0.058-1.199
MRQ-0.058TTM0.246-0.304
TTM0.246YOY-1.713+1.959
TTM0.2465Y-1.300+1.545
5Y-1.30010Y-1.3000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.257-2.341+1.084
MRQ-0.058-2.997+2.939
TTM0.246-2.882+3.128
YOY-1.713-3.553+1.840
5Y-1.300-6.262+4.962
10Y-1.300-6.288+4.988
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Synaptogenix Inc:

  • The EOD is -1.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.054. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.629. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.174MRQ-0.054-1.120
MRQ-0.054TTM-0.629+0.574
TTM-0.629YOY-2.505+1.876
TTM-0.6295Y-2.426+1.797
5Y-2.42610Y-2.4260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.174-2.932+1.758
MRQ-0.054-3.739+3.685
TTM-0.629-3.776+3.147
YOY-2.505-4.917+2.412
5Y-2.426-7.942+5.516
10Y-2.426-8.503+6.077
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Synaptogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.01 means the investor is paying $0.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Synaptogenix Inc:

  • The EOD is 0.196. Based on the equity, the company is cheap. +2
  • The MRQ is 0.009. Based on the equity, the company is cheap. +2
  • The TTM is 0.110. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.196MRQ0.009+0.187
MRQ0.009TTM0.110-0.101
TTM0.110YOY0.851-0.741
TTM0.1105Y0.660-0.549
5Y0.66010Y0.6600.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1961.843-1.647
MRQ0.0092.249-2.240
TTM0.1102.301-2.191
YOY0.8512.412-1.561
5Y0.6603.782-3.122
10Y0.6604.212-3.552
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Synaptogenix Inc.

3.1. Institutions holding Synaptogenix Inc

Institutions are holding 3.098% of the shares of Synaptogenix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Renaissance Technologies Corp1.99340.00025408645175642221.3047
2023-12-31Geode Capital Management, LLC0.5693015447193857154.8438
2023-12-31Vanguard Group Inc0.252506852251131294.0084
2023-12-31Cannell Peter B & CO Inc0.11060.00033000000
2023-12-31Platform Technology Partners0.09260.00172513800
2023-12-31State Street Corporation0.074102010000
2023-12-31Saxony Capital Management LLC0.07370.007220000200000
2023-12-31Hayek Kallen Investment Management0.06450.00211750000
2023-12-31Elevated Capital Advisors, LLC0.05880.001415950550052.6316
2023-12-31Advisor Group Holdings, Inc.0.012703448-2800-44.8143
2023-12-31Morgan Stanley - Brokerage Accounts0.00840228700
2023-12-31Orion Capital Management LLC0.00740.0003200000
2023-12-31UBS Group AG0.00660180018000
2023-12-31BlackRock Inc0.0035094221028.6885
2023-12-31Acadian Asset Management LLC0.0022059100
2023-12-31Tower Research Capital LLC0.00140386-144-27.1698
2023-12-31Newbridge Financial Services Group, Inc.0.0011030000
2023-12-31Wells Fargo & Co0.0005014999198
2023-12-31Royal Bank of Canada0.0004011800
2023-12-311832 Asset Management L.P0.0001025250
Total 3.33380.0132904591+687242+76.0%

3.2. Funds holding Synaptogenix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Fidelity Extended Market Index0.42090.00015191-47-0.8973
2024-03-31NT Ext Equity Mkt Idx Fd - L0.01540474900
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.01310402800
2024-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01050323720.0618
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.222202740-1-0.0365
2023-12-31SSgA U.S. Extended Market Index Class I0.00810250000
2023-12-31SSgA U.S. Total Market Index Strategy0.00230721-17-2.3035
2023-12-31NT US Market Cap Idx Fd - L0.0021066100
2023-12-31Blackstone Alternative Multi-Strategy I0.001304004000
2024-04-30Fidelity Total Market Index0.0242029800
2024-04-30Fidelity Series Total Market Index0.0234028900
2024-04-30Fidelity Nasdaq Composite Index0.0162020000
2024-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000601936348.4615
2024-03-31Northern Trust Extended Eq Market Idx0.00060190-4559-95.9992
2024-04-30Spartan Total Market Index Pool E0.01030127-1-0.7813
2024-03-31NT Quality SCC US Fund - L0.0004012500
2024-05-31State St US Extended Mkt Indx NL Cl C0.0081010000
2024-04-30Spartan Extended Market Index Pool E0.005807247188
2024-05-31State St US Ttl Mkt Indx SL Cl I0.002503100
2024-03-31Northern Trust Wilshire 50000.0001026-635-96.0666
Total 0.78810.000125878-4748-18.3%

3.3. Insider Transactions

Insiders are holding 2.143% of the shares of Synaptogenix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-12-16Daniel L AlkonSELL78729.25
2022-12-16William S SingerSELL108029.25
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Synaptogenix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---4.047-100%-0.0020%1.153-100%1.153-100%
Book Value Per Share--20.74611.951+74%4.411+370%8.821+135%8.821+135%
Current Ratio--7.14011.031-35%36.296-80%22.866-69%22.866-69%
Debt To Asset Ratio--0.1780.168+6%0.048+268%0.079+126%0.079+126%
Debt To Equity Ratio--0.2270.206+10%0.051+341%0.093+145%0.093+145%
Dividend Per Share--0.0000.022-100%0.013-100%0.008-99%0.008-99%
Eps---0.808-0.525-35%-0.134-83%-0.949+18%-0.949+18%
Free Cash Flow Per Share---0.864-0.502-42%-0.334-61%-0.726-16%-0.726-16%
Free Cash Flow To Equity Per Share---0.864-0.557-36%0.183-574%-1.385+60%-1.385+60%
Gross Profit Margin--1.0011.000+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max--5.327--------
Intrinsic Value_10Y_min--3.830--------
Intrinsic Value_1Y_max---1.308--------
Intrinsic Value_1Y_min---1.286--------
Intrinsic Value_3Y_max---2.527--------
Intrinsic Value_3Y_min---2.441--------
Intrinsic Value_5Y_max---2.054--------
Intrinsic Value_5Y_min---2.027--------
Market Cap5006913.800+95%231847.2403026962.050-92%24244956.700-99%18262737.389-99%18262737.389-99%
Net Profit Margin---96.941-24.235-75%--100%-5.386-94%-5.386-94%
Operating Margin---207.554-51.889-75%--100%-11.531-94%-11.531-94%
Operating Ratio--207.55451.888+300%-+100%11.531+1700%11.531+1700%
Pb Ratio0.196+95%0.0090.110-92%0.851-99%0.660-99%0.660-99%
Pe Ratio-1.257-2060%-0.0580.246-124%-1.713+2843%-1.300+2133%-1.300+2133%
Price Per Share4.060+95%0.1880.457-59%3.463-95%3.079-94%3.079-94%
Price To Free Cash Flow Ratio-1.174-2060%-0.054-0.629+1056%-2.505+4506%-2.426+4361%-2.426+4361%
Price To Total Gains Ratio98174.780+95%4546.0241136.115+300%-8.231+100%323.371+1306%323.371+1306%
Quick Ratio--7.3759.258-20%35.258-79%21.745-66%21.745-66%
Return On Assets---0.032-0.041+27%-0.042+31%-0.108+237%-0.108+237%
Return On Equity---0.041-0.051+25%-0.041+1%-0.120+194%-0.120+194%
Total Gains Per Share--0.0004.069-100%0.011-100%1.160-100%1.160-100%
Usd Book Value--25584198.00026626149.250-4%31305283.750-18%25618568.2780%25618568.2780%
Usd Book Value Change Per Share---4.047-100%-0.0020%1.153-100%1.153-100%
Usd Book Value Per Share--20.74611.951+74%4.411+370%8.821+135%8.821+135%
Usd Dividend Per Share--0.0000.022-100%0.013-100%0.008-99%0.008-99%
Usd Eps---0.808-0.525-35%-0.134-83%-0.949+18%-0.949+18%
Usd Free Cash Flow---1066000.000-1136016.500+7%-2357019.258+121%-1988530.168+87%-1988530.168+87%
Usd Free Cash Flow Per Share---0.864-0.502-42%-0.334-61%-0.726-16%-0.726-16%
Usd Free Cash Flow To Equity Per Share---0.864-0.557-36%0.183-574%-1.385+60%-1.385+60%
Usd Market Cap5006913.800+95%231847.2403026962.050-92%24244956.700-99%18262737.389-99%18262737.389-99%
Usd Price Per Share4.060+95%0.1880.457-59%3.463-95%3.079-94%3.079-94%
Usd Profit---995969.000-1330672.250+34%-981740.500-1%-2247785.556+126%-2247785.556+126%
Usd Revenue--10274.0002568.500+300%-+100%570.778+1700%570.778+1700%
Usd Total Gains Per Share--0.0004.069-100%0.011-100%1.160-100%1.160-100%
 EOD+6 -2MRQTTM+12 -24YOY+10 -245Y+15 -2110Y+15 -21

4.2. Fundamental Score

Let's check the fundamental score of Synaptogenix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.257
Price to Book Ratio (EOD)Between0-10.196
Net Profit Margin (MRQ)Greater than0-96.941
Operating Margin (MRQ)Greater than0-207.554
Quick Ratio (MRQ)Greater than17.375
Current Ratio (MRQ)Greater than17.140
Debt to Asset Ratio (MRQ)Less than10.178
Debt to Equity Ratio (MRQ)Less than10.227
Return on Equity (MRQ)Greater than0.15-0.041
Return on Assets (MRQ)Greater than0.05-0.032
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Synaptogenix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.080
Ma 20Greater thanMa 504.246
Ma 50Greater thanMa 1004.491
Ma 100Greater thanMa 2004.624
OpenGreater thanClose4.140
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets31,114
Total Liabilities5,529
Total Stockholder Equity24,347
 As reported
Total Liabilities 5,529
Total Stockholder Equity+ 24,347
Total Assets = 31,114

Assets

Total Assets31,114
Total Current Assets30,533
Long-term Assets581
Total Current Assets
Cash And Cash Equivalents 28,661
Short-term Investments 1,439
Other Current Assets 433
Total Current Assets  (as reported)30,533
Total Current Assets  (calculated)30,533
+/-0
Long-term Assets
Property Plant Equipment 19
Long Term Investments 554
Other Assets 0
Long-term Assets  (as reported)581
Long-term Assets  (calculated)572
+/- 9

Liabilities & Shareholders' Equity

Total Current Liabilities4,276
Long-term Liabilities1,253
Total Stockholder Equity24,347
Total Current Liabilities
Accounts payable 445
Other Current Liabilities 3,832
Total Current Liabilities  (as reported)4,276
Total Current Liabilities  (calculated)4,276
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,253
Long-term Liabilities  (calculated)0
+/- 1,253
Total Stockholder Equity
Common Stock2
Retained Earnings -33,611
Accumulated Other Comprehensive Income 1
Other Stockholders Equity 56,718
Total Stockholder Equity (as reported)24,347
Total Stockholder Equity (calculated)23,110
+/- 1,237
Other
Capital Stock824
Cash and Short Term Investments 30,100
Common Stock Shares Outstanding 964
Liabilities and Stockholders Equity 31,114
Net Debt -28,661
Net Invested Capital 22,053
Net Working Capital 22,529



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
17,898
0
0
29,150
6,751
16,347
32,960
32,359
35,525
32,353
29,579
27,351
38,608
36,529
33,437
32,360
31,114
31,114
31,11431,11432,36033,43736,52938,60827,35129,57932,35335,52532,35932,96016,3476,75129,1500017,8980
   > Total Current Assets 
0
17,876
0
0
29,126
6,729
16,326
32,940
32,340
35,504
32,334
29,558
27,329
38,586
36,507
33,416
32,341
30,533
30,533
30,53330,53332,34133,41636,50738,58627,32929,55832,33435,50432,34032,94016,3266,72929,1260017,8760
       Cash And Cash Equivalents 
0
17,382
0
0
27,000
5,795
14,848
31,702
31,295
34,214
31,282
28,755
26,334
37,478
35,781
32,899
31,728
28,661
28,661
28,66128,66131,72832,89935,78137,47826,33428,75531,28234,21431,29531,70214,8485,79527,0000017,3820
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,439
1,439
1,4391,43900000000000000000
       Net Receivables 
0
0
0
0
862
127
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001278620000
       Other Current Assets 
0
494
0
0
1,265
806
1,477
1,238
1,046
19
720
523
395
739
586
386
238
58
433
43358238386586739395523720191,0461,2381,4778061,265004940
   > Long-term Assets 
0
22
0
0
23
22
21
20
18
20
19
21
22
22
22
21
20
581
581
5815812021222222211920182021222300220
       Property Plant Equipment 
0
22
0
0
23
22
21
20
18
20
19
21
22
22
22
21
20
19
19
19192021222222211920182021222300220
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
562
554
55456200000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000
> Total Liabilities 
0
479
0
0
1,300
1,612
937
770
1,007
1,995
669
626
684
3,193
2,343
6,530
3,932
5,529
5,529
5,5295,5293,9326,5302,3433,1936846266691,9951,0077709371,6121,300004790
   > Total Current Liabilities 
0
479
0
0
1,300
1,612
937
770
1,007
1,995
669
626
684
1,313
1,277
2,773
1,818
4,276
4,276
4,2764,2761,8182,7731,2771,3136846266691,9951,0077709371,6121,300004790
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,265
0
0
0
0002,265000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,265
0
0
0
0002,265000000000000000
       Accounts payable 
0
413
0
0
1,190
1,260
759
648
935
1,297
401
281
483
660
356
439
214
445
445
4454452144393566604832814011,2979356487591,2601,190004130
       Other Current Liabilities 
0
66
0
0
110
352
178
122
72
698
268
345
200
653
921
2,334
1,604
0
3,832
3,83201,6042,3349216532003452686987212217835211000660
   > Long-term Liabilities 
0
413
0
0
1,190
1,260
759
648
935
1,297
401
281
483
1,880
1,067
3,757
2,114
1,253
1,253
1,2531,2532,1143,7571,0671,8804832814011,2979356487591,2601,190004130
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,602
0
0
0
0
0
000004,6020000000000000
> Total Stockholder Equity
0
17,419
0
0
27,849
5,139
15,409
32,190
31,351
33,530
31,684
28,953
26,667
35,415
34,186
26,908
28,429
25,584
24,347
24,34725,58428,42926,90834,18635,41526,66728,95331,68433,53031,35132,19015,4095,13927,8490017,4190
   Common Stock
0
17,419
0
0
27,849
1
1
1
1
1
1
1
1
1
1
1
2
0
2
2021111111111127,8490017,4190
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,077
-1,688
0
1
10-1,688-2,077000000000000000
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
17,419
0
0
27,849
6,668
20,093
39,168
41,256
47,671
49,103
50,124
50,864
52,524
53,273
58,927
60,808
0
56,718
56,718060,80858,92753,27352,52450,86450,12449,10347,67141,25639,16820,0936,66827,8490017,4190



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-6
Gross Profit-6-6
 
Operating Income (+$)
Gross Profit-6
Operating Expense-8,308
Operating Income-8,314-8,314
 
Operating Expense (+$)
Research Development1,975
Selling General Administrative6,339
Selling And Marketing Expenses6
Operating Expense8,3088,320
 
Net Interest Income (+$)
Interest Income1,519
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,519
 
Pretax Income (+$)
Operating Income-8,314
Net Interest Income1,519
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,039-10,589
EBIT - interestExpense = -8,314
1,702
-6,039
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-8,314-6,039
Earnings Before Interest and Taxes (EBITDA)-8,307
 
After tax Income (+$)
Income Before Tax-6,039
Tax Provision-0
Net Income From Continuing Ops-560-6,039
Net Income-6,039
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,314
Total Other Income/Expenses Net2,275-1,519
 

Technical Analysis of Synaptogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Synaptogen. The general trend of Synaptogen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Synaptogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Synaptogenix Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.15 < 4.3501 < 4.65.

The bearish price targets are: 3.8908 > 3.865 > 3.525.

Tweet this
Synaptogenix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Synaptogenix Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Synaptogenix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Synaptogenix Inc. The current macd is -0.11521895.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Synaptogen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Synaptogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Synaptogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Synaptogenix Inc Daily Moving Average Convergence/Divergence (MACD) ChartSynaptogenix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Synaptogenix Inc. The current adx is 12.23.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Synaptogen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Synaptogenix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Synaptogenix Inc. The current sar is 4.95839443.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Synaptogenix Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Synaptogenix Inc. The current rsi is 41.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Synaptogenix Inc Daily Relative Strength Index (RSI) ChartSynaptogenix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Synaptogenix Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Synaptogen price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Synaptogenix Inc Daily Stochastic Oscillator ChartSynaptogenix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Synaptogenix Inc. The current cci is -93.36027867.

Synaptogenix Inc Daily Commodity Channel Index (CCI) ChartSynaptogenix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Synaptogenix Inc. The current cmo is -22.16180062.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Synaptogenix Inc Daily Chande Momentum Oscillator (CMO) ChartSynaptogenix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Synaptogenix Inc. The current willr is -83.89830508.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Synaptogenix Inc Daily Williams %R ChartSynaptogenix Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Synaptogenix Inc.

Synaptogenix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Synaptogenix Inc. The current atr is 0.2997035.

Synaptogenix Inc Daily Average True Range (ATR) ChartSynaptogenix Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Synaptogenix Inc. The current obv is 785,541.

Synaptogenix Inc Daily On-Balance Volume (OBV) ChartSynaptogenix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Synaptogenix Inc. The current mfi is 67.47.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Synaptogenix Inc Daily Money Flow Index (MFI) ChartSynaptogenix Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Synaptogenix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Synaptogenix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Synaptogenix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.080
Ma 20Greater thanMa 504.246
Ma 50Greater thanMa 1004.491
Ma 100Greater thanMa 2004.624
OpenGreater thanClose4.140
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Synaptogen with someone you think should read this too:
  • Are you bullish or bearish on Synaptogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Synaptogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Synaptogenix Inc

I send you an email if I find something interesting about Synaptogenix Inc.


Stay informed about Synaptogenix Inc.

Receive notifications about Synaptogenix Inc in your mailbox!